Valeant to buy Bausch & Lomb for $8.7 billion

Published May 27, 2013

| Reuters

Valeant Pharmaceuticals International Inc said on Monday that it had inked an $8.7 billion cash deal to take over eye health company Bausch & Lomb Holdings.

The deal, to be financed through debt and equity, will see some $4.5 billion go to an investor group led by Warburg Pincus LLC, with some $4.2 billion used to pay down Bausch & Lomb's outstanding debt.

(Reporting by Julie Gordon)

URL

http://www.foxbusiness.com/news/2013/05/27/valeant-to-buy-bausch-lomb-for-87-billion/